NCT01223287

Brief Summary

This observational study was conducted to design and test a physiologic definition for bronchopulmonary dysplasia at 36 weeks of life. Infants were studied in a supine position with the pulse oximeter in position with good signal prior to collecting baseline data. Feedings and medications were given 30 minutes before the evaluation. Baseline data was collected on infant's current oxygen. Then, the infants were weaned to room air for 30 minutes. If saturations remain ≥90%, the infant was considered to have passed the oxygen reduction challenge (to NOT have BPD). The infant should then be placed back in his/her baseline oxygen. If the infant has saturations \<90% for 5 continuous minutes or \<80% for 15 seconds, the infant should be immediately placed back in his/her baseline oxygen, and the infant was considered to have NOT passed the challenge (to have BPD).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
410

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2005

Typical duration for all trials

Geographic Reach
1 country

21 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2005

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

October 14, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 18, 2010

Completed
Last Updated

September 26, 2017

Status Verified

September 1, 2017

Enrollment Period

3 years

First QC Date

October 14, 2010

Last Update Submit

September 22, 2017

Conditions

Keywords

NICHD Neonatal Research NetworkExtremely Low Birth Weight (ELBW)Very Low Birth Weight (VLBW)PrematurityMechanical ventilationChronic Lung Disease (CLD)

Outcome Measures

Primary Outcomes (1)

  • Bronchopulmonary dysplasia

    36 weeks of life

Eligibility Criteria

Age36 Weeks - 37 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Premature infants on mechanical ventilation at 36 weeks of life.

You may qualify if:

  • Infant with birthweight 401-1500 grams
  • Alive at 36+1 week corrected age
  • On supplemental oxygen as follows:
  • A. Infants receiving oxygen by hood at rest:
  • A1. Oxygen by hood \<27% with majority\* of saturations ≥ 90% in prior 24 hours.
  • A2. Oxygen by hood 27-30% with majority\* of saturations ≥ 96% in prior 24 hours
  • B. Infants receiving oxygen by nasal cannula at restΔ:
  • B1. Oxygen by nasal cannula \<27% EFFECTIVE\*\* oxygen and majority\* of saturations ≥90% in prior 24 hours.
  • B2. Oxygen by nasal cannula 27-30% EFFECTIVE\*\* oxygen and majority\* saturations ≥96% on prior 24 hours.
  • C. Infants receiving room air by nasal cannula at ANY liter per minute (lpm) flow.

You may not qualify if:

  • Need for mechanical ventilation or continuous positive airway pressure (CPAP)
  • Oxygen by hood \>30%
  • Oxygen by nasal cannula \>30% effective oxygen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (21)

University of Alabama

Birmingham, Alabama, 35249-7335, United States

Location

Stanford University

Palo Alto, California, 94304, United States

Location

University of California at San Diego

San Diego, California, 92103-8774, United States

Location

Yale University

New Haven, Connecticut, 06504, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

Emory University

Atlanta, Georgia, 30303, United States

Location

Indiana University

Indianapolis, Indiana, 46202, United States

Location

University of Iowa

Iowa City, Iowa, 52242, United States

Location

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

Wayne State University

Detroit, Michigan, 48201, United States

Location

University of New Mexico

Albuquerque, New Mexico, 87131, United States

Location

University of Rochester

Rochester, New York, 14642, United States

Location

Wake Forest University

Charlotte, North Carolina, 27157, United States

Location

RTI International

Durham, North Carolina, 27705, United States

Location

Duke University

Durham, North Carolina, 27710, United States

Location

Cincinnati Children's Medical Center

Cincinnati, Ohio, 45267, United States

Location

Case Western Reserve University, Rainbow Babies and Children's Hospital

Cleveland, Ohio, 44106, United States

Location

Brown University, Women & Infants Hospital of Rhode Island

Providence, Rhode Island, 02905, United States

Location

University of Texas Southwestern Medical Center at Dallas

Dallas, Texas, 75235, United States

Location

University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

University of Utah

Salt Lake City, Utah, 84108, United States

Location

Related Publications (1)

  • Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, Auten K, Newman N, Rowan G, Grisby C, Arnell K, Miller L, Ball B, McDavid G; National Institute of Child Health and Human Development Neonatal Research Network. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004 Nov;114(5):1305-11. doi: 10.1542/peds.2004-0204.

    PMID: 15520112BACKGROUND

Related Links

MeSH Terms

Conditions

Premature BirthBronchopulmonary Dysplasia

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVentilator-Induced Lung InjuryLung InjuryLung DiseasesRespiratory Tract DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Michele C. Walsh, MD MS

    Case Western Reserve University, Rainbow Babies & Children's Hospital

    PRINCIPAL INVESTIGATOR
  • Abbot R. Laptook, MD

    Brown University, Women & Infants Hospital of Rhode Island

    PRINCIPAL INVESTIGATOR
  • Kurt Schibler, MD

    Children's Hospital Medical Center, Cincinnati

    PRINCIPAL INVESTIGATOR
  • Ronald N. Goldberg, MD

    Duke University

    PRINCIPAL INVESTIGATOR
  • Barbara J. Stoll, MD

    Emory University

    PRINCIPAL INVESTIGATOR
  • Brenda B. Poindexter, MD MS

    Indiana University

    PRINCIPAL INVESTIGATOR
  • Krisa P. Van Meurs, MD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Ivan D. Franz, III, MD

    Tufts Medical Center

    PRINCIPAL INVESTIGATOR
  • Waldemar A. Carlo, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Neil N. Finer, MD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Edward F. Bell, MD

    University of Iowa

    PRINCIPAL INVESTIGATOR
  • Charles R. Bauer, MD

    University of Miami

    PRINCIPAL INVESTIGATOR
  • Kristi L. Watterberg, MD

    University of New Mexico

    PRINCIPAL INVESTIGATOR
  • Dale L. Phelps, MD

    University of Rochester

    PRINCIPAL INVESTIGATOR
  • Roger G. Faix, MD

    University of Utah

    PRINCIPAL INVESTIGATOR
  • Pablo J. Sanchez, MD

    University of Texas, Southwestern Medical Center at Dallas

    PRINCIPAL INVESTIGATOR
  • Kathleen A. Kennedy, MD MPH

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR
  • T. Michael O'Shea, MD MPH

    Wake Forest University

    PRINCIPAL INVESTIGATOR
  • Seetha Shankaran, MD

    Wayne State University

    PRINCIPAL INVESTIGATOR
  • Richard A. Ehrenkranz, MD

    Yale University

    PRINCIPAL INVESTIGATOR
  • Abhik Das, PhD

    RTI International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2010

First Posted

October 18, 2010

Study Start

May 1, 2005

Primary Completion

May 1, 2008

Study Completion

September 1, 2008

Last Updated

September 26, 2017

Record last verified: 2017-09

Locations